Inimmune’s mission is to develop and deliver transformative vaccines

Inimmune’s mission is to develop and deliver transformative vaccines and immunotherapeutics that address critical unmet needs in patient care. The company’s vision is to lead the field of immunotherapy and vaccines by creating novel solutions that improve the lives of patients across a range of conditions. The company is developing new immunotherapeutics designed to enhance the body’s ability to target and destroy cancer cells, offering potential new treatments for various types of cancer.Inimmune is working on innovative treatments to address allergic rhinitis and food allergies, aiming to provide long−lasting relief and improved quality of life for patients.The company is focused on creating novel vaccines to prevent and treat infectious diseases, utilizing advanced immunological techniques to develop effective and safe vaccine candidates.Inimmune is developing new antibiotics to combat bacterial infections, addressing the growing issue of antibiotic resistance with novel approaches to drug design and formulation.